# Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications

> **NCT02644876** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 864 (actual)

## Conditions studied

- Postoperative Complications

## Interventions

- **DRUG:** Penehyclidine inhalation
- **DRUG:** Placebo inhalation

## Key facts

- **NCT ID:** NCT02644876
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2018-11-08
- **Final completion:** 2018-12-10
- **Target enrollment:** 864 (ACTUAL)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02644876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02644876, "Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02644876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*